Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Glantz

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Current Treatment Options in Oncology|October 13, 2006
Chemotherapeutic options for primary brain tumorsLyndon Kim, Michael Glantz
Cerebrospinal Fluid Research|March 28, 2008
Report on a conference analyzing the role of cerebrospinal fluid prophylaxis for brain tumorsMichael Glantz, Conrad Johanson
Seminars in Oncology|August 8, 2009
The science of prevention: novel strategies for and new insights into central nervous system prophylaxis in patients with cancerMichael Glantz, Lawrence Recht
Journal of Neurosurgery|February 10, 2019
Editorial. When can we be positive about p values?Michael Glantz, Nicholas Brandmeir
Expert Review of Neurotherapeutics|April 28, 2005
Leukemia and lymphoma: what is the role for intrathecal prophylactic treatment in adults?Guillermo Garcia-Manero, Michael Glantz
Cancer|February 9, 2008
Myelomatous meningitisMarc C Chamberlain, Michael Glantz
Seminars in Oncology|August 8, 2009
Statistical and trial design considerations in central nervous system prophylaxis studiesJennifer A Smith, Michael Glantz
JAMA Oncology|September 30, 2016
Extent of Resection and Survival in Glioblastoma Multiforme-ReplyTimothy J Brown, Michael Glantz
Neurology|March 15, 2006
Ventriculoperitoneal shunt in patients with leptomeningeal metastasisMarc C Chamberlain, Michael Glantz
Seminars in Neurology|January 8, 2005
Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: a review of the literatureNatalia Colocci, Michael Glantz, Lawrence Recht
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Current Treatment Options in Oncology|October 13, 2006
Chemotherapeutic options for primary brain tumorsLyndon Kim, Michael Glantz
Cerebrospinal Fluid Research|March 28, 2008
Report on a conference analyzing the role of cerebrospinal fluid prophylaxis for brain tumorsMichael Glantz, Conrad Johanson
Seminars in Oncology|August 8, 2009
The science of prevention: novel strategies for and new insights into central nervous system prophylaxis in patients with cancerMichael Glantz, Lawrence Recht
Journal of Neurosurgery|February 10, 2019
Editorial. When can we be positive about p values?Michael Glantz, Nicholas Brandmeir
Expert Review of Neurotherapeutics|April 28, 2005
Leukemia and lymphoma: what is the role for intrathecal prophylactic treatment in adults?Guillermo Garcia-Manero, Michael Glantz
Cancer|February 9, 2008
Myelomatous meningitisMarc C Chamberlain, Michael Glantz
Seminars in Oncology|August 8, 2009
Statistical and trial design considerations in central nervous system prophylaxis studiesJennifer A Smith, Michael Glantz
JAMA Oncology|September 30, 2016
Extent of Resection and Survival in Glioblastoma Multiforme-ReplyTimothy J Brown, Michael Glantz
Neurology|March 15, 2006
Ventriculoperitoneal shunt in patients with leptomeningeal metastasisMarc C Chamberlain, Michael Glantz
Seminars in Neurology|January 8, 2005
Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: a review of the literatureNatalia Colocci, Michael Glantz, Lawrence Recht
Pageof 8